OVERVIEW
TAP M&A is a leading independent investment banking firm for M&A and corporate finance. We focus on M&A activity in the medium-sized business sector in Germany, Switzerland and Austria.
As an enterprising investment banking firm, we have longstanding experience in negotiating and executing transactions that are often unique and always of extreme importance to our clients. Our result-oriented compensation plan ensures our client's objectives are always our top focus.
TAP M&A serves corporate organizations, entrepreneurs, family offices, financial institutions and private equity funds. We are managed by the founding partner and are not part of any larger institution that could create competing interests.
Team
Dr. Ron Davidson,
Managing Director
Gerhard Friedel,
Financing Expert
Dr. Ulrich Scheipers,
Medical Technology expert
Tina Umbach, Partner
Prof. Dr. Florian Wiedemann,
Partner
Dr. Liming Ge, Partner
with focus on pharma and biotech
Dr. Ron Davidson is a founding partner and managing director of TAP M&A. He has been involved in more than 50 transactions during his career as an investment banker and transaction advisor.
Prior to founding TAP M&A in 2014, Dr. Davidson was Managing Director of an investment bank where he built the middle market business. He began his corporate finance career at KPMG, most recently as an authorized signatory. He was also involved as co-founder and managing director of an ebook company. He received his diploma in business administration from the University of Regensburg, where he worked as a research assistant at the Chair of Finance.
Dr. Davidson has outstanding knowledge of business valuation and is multilingual (German, English, Hebrew and French).
Gerhard Friedel holds a degree in economics from the University of Augsburg. He has more than 20 years of experience in the fields of auditing and in particular corporate finance from his work with renowned German and international commercial banks as well as alternative debt capital providers.
He is an expert in the financing of German SMEs across all industries and situations and has a correspondingly broad network with equity, debt and mezzanine capital providers.
Gerhard Friedel speaks German, English and Italian.
Dr. Ulrich Scheipers has been active in the international medical technology industry for over 15 years. He has accompanied the development of complex medical products throughout the entire product lifecycle, from early research stages, through clinical trials, to certification, commercialization and B2C/B2B sales.
His current focus is on mergers & acquisitions, business development and strategy. Dr. Scheipers is an electrical engineer and holds a PhD in pattern recognition and artificial intelligence in radiology. He has worked in numerous disciplines in medical technology. These include cardiology, radiotherapy, orthopedics, cardiac surgery, emergency medicine, dental technology, surgical processes and equipment, and general capital equipment for hospitals.
Dr. Scheipers has a large international network in medical technology and is multilingual (German, English, French and Spanish).
Tina Umbach holds a degree in business administration (University of Cologne). She gained many years of corporate finance experience at KPMG. Subsequently, as Senior Manager, she drove the implementation of Media Saturn's European expansion strategy before co-founding "stilrad" as an entrepreneur.
In the last few years, Ms. Umbach has supported start-up companies in particular. In addition, retail companies are another focus of her consulting.
Ms. Umbach speaks German, English and French.
Prof. Dr. Florian Wiedemann has more than 20 years of experience in corporate finance and transaction advisory, among others as Managing Director of a global investment bank and Director at KPMG Corporate Finance. He holds a PhD from the University of St. Gallen (HSG) and a professorship in General Business Administration, in particular Financing at FOM University.
Prof. Wiedemann has a large international network of financial investors and family offices. He is himself an angel investor in several start-ups and acted as interim CFO in various growth companies.
He speaks German, English and French.
Dr. Liming Ge holds a PhD in chemistry from Harvard University and an MBA from European University Business College. As an investment banker and transaction advisor, he has advised on over 20 transactions, mostly biotech and Asia related.
In the past, he has also led several German biotech companies over the years and established a corresponding European network in biotech and pharma.
The main focus of his consulting work is cross-border deal initiation and support.
Dr. Ge is multilingual (Chinese, German, English).
Noam Davidson, IT-Expert
Noam Davidson is an IT expert and partner at TAP M&A.
In the course of his career, he has successfully advised numerous international companies in IT. His technical expertise covers, for example, ERP systems, integration platforms and cloud computing. Mr. Davidson studied computer science at LMU Munich and completed his MBA at IDC Herzliya in Israel. Among other things, he was the founder and CTO of an ebook company.
Noam Davidson is multilingual (German, English, Hebrew).
SEARCH & BUY-SIDE ADVICE
We support corporate entities, entrepreneurs, family offices, financial institutions and private equity funds with buy-side advice. Our clients benefit from our experience in
identifying and contacting potential target companies
analyzing potential takeover candidates, particularly in view of finances and
evaluating companies with an added focus on potential synergies.
Moreover, we can also assist in deal
structuring
pricing
negotiating and
financing.
ACTUAL REFERENCE
TAP M&A advised on the acquisition of a stake in inomed by JUNO Family Office. inomed's products make an important contribution to the therapy of neurological diseases and interventions on the nervous system.
SELECTED REFERENCES
SELL-SIDE ADVICE
We are experts in executing competitive sell-side merger and acquisition processes for our clients. This includes:
identifying, selecting, and contacting potential buyers
preparing extensive information packages in both English and German, including description of the investment case as well as presentation and interpretation of financial data.
assisting in data room creation, allowing potential buyers to execute due diligence at a later stage of the process and
negotiating Sales and Purchase Agreements through final signing.
ACTUAL REFERENCE
TAP M&A successfully advised on the sale of the Christian Koenen Group to Afinum.
The Christian Koenen Group is the global technology leader and Europe-wide market-leading specialist for the development and production of high-precision premium stencils and screens for technical printing. The stencils and screens are used as process-critical precision tools e.g. in the production of semiconductor components as well as in the assembly of printed circuit boards (PCB).
The company acts as a full-range supplier and covers the entire value chain - from technical consulting and data preparation to development, production and logistics. It is characterised by state-of-the-art production capacities including clean rooms in Germany and Hungary, excellent customer service and a fully equipped application centre. With the highest product quality, recognised reliability and short delivery times, the Christian Koenen Group has become a trusted partner to an established blue-chip customer base, serving broadly diversified end markets including the semiconductor, automotive, electrical and medical industries, among others. The company was founded in 2003, is headquartered in Ottobrunn (Greater Munich) and employs approximately 150 people.
TAP M&A exclusively accompanied the investor search and contacted selected financial investors. With Afinum, a strong partner was found who is convinced of the company's philosophy and would like to advance the growth together with Mr. Christian Koenen. The further expansion in the areas of semiconductors and medical technology applications as well as the advancing internationalisation are intended to further broaden the strategic positioning of the company and enable additional growth potential. The transfer of technological know-how to new end markets around renewable energies such as solar modules and fuel cells also offers attractive growth opportunities.
SELECTED REFERENCES
CORPORATE FINANCE
We assist clients with debt structuring and equity financing such as:
growth capital
mezzanine capital
acquisition financing or
recapitalization.
Our independence ensures no conflict of interests - we can negotiate the best possible solution for our clients.
Our wide range of services also includes:
preparation of a business plan
debt capacity analysis
draft of financing memorandums as well as
selection of institutional investors or banks and negotiation of financing conditions.
Our clients benefit from our excellent contacts with leading institutional investors, family offices and banks as well as our transaction-management capabilities.
SELECTED REFERENCES
Please contact us for more Information or in case of interest.
Phone: +49 89 244 1909 4-0
By providing your contact details, you give your consent that your data will be used for information purposes within TAP M&A. We will not give your data to third parties. If you would like to have that information deleted from our records, please notify us by Email at info@tap-ma.com.